US health regulators tried to regulate lab tests. A court reversed it.
What happened
US health regulators tried to expand their power over diagnostic tests made in labs. A court stopped them, which means labs can continue to develop and use their own tests without the stricter federal oversight that was planned.
Why it matters
US health regulators wanted to apply the same strict approval process to lab-developed diagnostic tests as they do to other medical devices. This would have meant more paperwork, longer timelines, and higher costs for labs creating new tests. Now, those labs can continue to operate under the previous rules, which means they can bring new tests to patients faster, but without the same federal review for safety and effectiveness.
The signal
Watch for new legislative efforts to regulate lab-developed tests, or for states to step in with their own rules.